Vanguard Health Care Fund Investor Shares (VGHCX) Alternatives
Vanguard Health Care Fund Investor Shares (VGHCX) belongs to the Health & Biotech Equities category. Below you'll find alternative mutual funds from the same category, ranked by key criteria, plus funds that investors commonly compare with VGHCX. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.
Cheapest Alternatives to VGHCX
VGHCX charges 0.30% annually. Among mutual funds in the Health & Biotech Equities category, these options have the lowest expense ratios among VGHCX alternatives.
| Symbol | Name | Expense Ratio | Inception | |
|---|---|---|---|---|
| Vanguard Health Care Index Fund Admiral Shares | 0.10% | Feb 5, 2004 | VGHCX vs VHCIX | |
| Vanguard Health Care Fund Admiral Shares | 0.25% | Nov 12, 2001 | VGHCX vs VGHAX | |
| Fidelity Advisor Health Care Fund Class Z | 0.59% | Oct 2, 2018 | VGHCX vs FIKCX | |
| Fidelity Advisor Biotechnology Fund Class Z | 0.61% | Oct 2, 2018 | VGHCX vs FIJYX | |
| T. Rowe Price Health Sciences Fund Class I | 0.67% | Dec 29, 1995 | VGHCX vs THISX |
Best Risk-Adjusted Alternatives to VGHCX
Among mutual funds in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.
| Symbol | Name | Risk / Return Rank | Inception | |
|---|---|---|---|---|
| Franklin Biotechnology Discovery Fund | 91 | Sep 14, 1997 | VGHCX vs FBDIX | |
| Eventide Healthcare & Life Sciences Fund | 88 | Dec 26, 2012 | VGHCX vs ETIHX | |
| Fidelity Advisor Biotechnology Fund I Class | 83 | Dec 27, 2000 | VGHCX vs FBTIX | |
| Fidelity Advisor Biotechnology Fund Class Z | 83 | Oct 2, 2018 | VGHCX vs FIJYX | |
| Fidelity Advisor Biotechnology Fund Class A | 83 | Dec 27, 2000 | VGHCX vs FBTAX |
Top Performing VGHCX Alternatives (YTD)
VGHCX alternatives from the Health & Biotech Equities category, sorted by year-to-date return.
| Symbol | Name | YTD Return | Inception | |
|---|---|---|---|---|
| Saratoga Health & Biotechnology Fund | -1.13% | Jul 14, 1999 | VGHCX vs SHPAX | |
| Live Oak Health Sciences Fund | -1.53% | Jun 28, 2001 | VGHCX vs LOGSX | |
| Fidelity Select Pharmaceuticals Portfolio | -2.56% | Jun 17, 2001 | VGHCX vs FPHAX | |
| Fidelity Advisor Biotechnology Fund Class Z | -2.59% | Oct 2, 2018 | VGHCX vs FIJYX | |
| Fidelity Advisor Biotechnology Fund I Class | -2.62% | Dec 27, 2000 | VGHCX vs FBTIX |
Lowest Volatility Alternatives to VGHCX
VGHCX alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.
| Symbol | Name | Volatility 1Y | Inception | |
|---|---|---|---|---|
| Invesco Health Care Fund | 15.67% | Aug 6, 1989 | VGHCX vs GGHCX | |
| BlackRock Health Sciences Opportunities Portfolio | 16.30% | Dec 20, 1999 | VGHCX vs SHSAX | |
| Health Sciences Opportunities Fund Class Instituti... | 16.32% | Oct 16, 2000 | VGHCX vs SHSSX | |
| Live Oak Health Sciences Fund | 16.35% | Jun 28, 2001 | VGHCX vs LOGSX | |
| Alger Health Sciences Fund | 16.42% | Apr 30, 2002 | VGHCX vs AHSAX |
Lowest Drawdown Alternatives to VGHCX
VGHCX alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.
| Symbol | Name | Max Drawdown 1Y | Inception | |
|---|---|---|---|---|
| Live Oak Health Sciences Fund | -7.65% | Jun 28, 2001 | VGHCX vs LOGSX | |
| Saratoga Health & Biotechnology Fund | -7.87% | Jul 14, 1999 | VGHCX vs SHPAX | |
| Vanguard Health Care Fund Admiral Shares | -9.19% | Nov 12, 2001 | VGHCX vs VGHAX | |
| AlphaCentric LifeSci Healthcare Fund | -9.47% | Nov 28, 2019 | VGHCX vs LYFIX | |
| Alger Health Sciences Fund | -9.67% | Apr 30, 2002 | VGHCX vs AHSAX |
Other Mutual Funds from Vanguard
Most popular Vanguard mutual funds on PortfoliosLab, across asset classes.
Often Compared With VGHCX
What investors most often compare with VGHCX, based on PortfoliosLab usage data.
Compare VGHCX with Any Fund or Stock
Compare VGHCX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.